All One Health Content – Page 123
-
NewsNew oral treatment reduces duration and symptoms of mild COVID-19
The treatment acts on the replication mechanism of SARS-CoV-2, the virus responsible for the disease, and reduces the severity and duration of some of the symptoms. In addition, it can be useful to treat the different mutations detected.
-
NewsCOVID-19 infection causes teen’s vocal cord paralysis in first-of-its-kind case
Physician-researchers have reported the first pediatric case of bilateral vocal cord paralysis after COVID-19 infection.
-
NewsScientists discover Ebola virus uses tunnelling nanotubes to infect cells
A new study indicates that Ebola virus creates and uses intercellular tunnels to move from cell to cell within the human body and evade treatments.
-
NewsKeto diet protects against epileptic seizures by changing gut microbiome
Researchers have demonstrated that the changes the high-fat, low-carbohydrate ketogenic diet causes in the human gut microbiome can confer protection against seizures in mice.
-
NewsAlgae could replace animal-derived protein for building muscle
A new study demonstrates that the ingestion of two of the most commercially available algal species are rich in protein which supports muscle remodeling in young healthy adults.
-
NewsPhotodynamic action weakens resistance to antibiotics in bacteria that attack airways
A study of photodynamic inactivation (PDI) showed it has a novel capacity to modify bacterial sensitivity to antibiotics according to dosage, reducing the resistance and persistence of both standard and clinical strains.
-
NewsResearchers discover how to sabotage antibiotic-resistant ‘superbugs’
Scientists say they have learned how to sabotage a key piece of machinery that pathogens use to infect their host cells, and have developed a test to identify the next-generation drugs to target this vulnerable cellular machinery.
-
NewsB cell deficient patients gain protective T cell immunity after SARS-CoV-2 vaccination, infection
Researchers found that vaccinated B cell-deficient individuals had significantly reduced risk of moderate and severe disease in comparison to those who were not vaccinated, despite an absence of anti-spike antibody responses.
-
NewsScientists construct a synthetic yeast genome
The yeast genome contains redesigned chromosome sequences that can shed light on the impact of genetic variations on individual traits and potentially be used to reveal the causes of genetic diseases
-
-
NewsProspective study clarifies the role of an innovative metagenomic tool in diagnosing infection
A new study aims to improve use of metagenomics using next-generation sequencing (mNGS) to identify a wide range of pathogens, including rare or novel microorganisms.
-
NewsResearchers to develop vaccine candidates against Marburg viruses
The multidisciplinary European consortium MARVAX will receive 7.4 million euros over the next four years for the research and development of vaccines against Marburg viruses.
-
NewsScientists reveal the molecular structure of a complex bacteriophage
For the first time, the molecular structure of a complete tailed virus with a flexible tail has been solved in unprecedented detail.
-
NewsResearchers ID opportunities to improve future HIV vaccine candidates
An effective HIV vaccine may need to prompt strong responses from immune cells called CD8+ T cells to protect people from acquiring HIV, according to a new study.
-
NewsMultiple sclerosis: Possible basis for vaccine researched
Researchers have shown that the risk of MS is particularly high in people with a combination of certain host factors and variants of the Epstein-Barr virus (EBV).
-
NewsNew research lays groundwork for personalized dietary supplements
Researchers used fluorescence-labeled inulin-grafted nanoparticles to track the interaction of inulin with gut bacteria - when incubated with human stool samples, a wider range of gut bacteria thatn previously assumed were found to bind to inulin.
-
NewsDenovAI uses artificial intelligence to discover therapeutic antibodies
Kashif Sadiq has founded a start-up – DenovAI – for broader, faster and cheaper antibody discovery using advanced machine learning and computational biophysics.
-
NewsNew software makes rapid inroads to find viral weapons for germ warfare
A new bioinformatics software program is paving the way for a rapid expansion of research into bacteriophages, the viruses or phages that play key roles in controlling bacteria.
-
News$1.3 million fund helps to introduce high school students to virus surveillance
The Icahn School of Medicine at Mount Sinai has received more than $1.3 million from the National Institute of General Medical Sciences of the National Institutes of Health (NIH) to expand the New York City Virus Hunters program.
-
NewsStudy reveals how the immune system fights to keep herpes at bay
A recent study, conducted using lab-engineered cells, unveils the precise maneuvers used by host and herpes simplex virus (HSV) in the fight for dominance of the cell.